BrightGene Bio-Medical Technology Co., Ltd.
USPTO PatentsView assignee record - 11 granted patents across 12 technology areas, recorded in grant years 2017–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Brightgene ranks #24,027 of 49,997 tracked US assignees by granted-patent volume, with 11 patents across 12 technology areas.
- #24,027
- of 49,997 US assignees by volume
- 30th percentile
- by Innovation Score (29.4/100)
- 12.8
- avg claims per patent
- +300%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R24027 · Foreign Corporation #24,027 · 11 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-MICRO 11 grants
- MID-PACK #24,027/49,997
- PHOTO-FINISH Brain Games L C
- CPC-FOCUS A61K · 12 areas
- INNOV-THIN 29.4/100
- CLAIMS-RICH 12.8 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +300% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Brain Games, L.C. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Brightgene’s 29.4 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Brightgene
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Northern Tool &… · near 29
Northern Tool &… · near
29 score
- BrightGene Bio-Medic… · this assignee 29
BrightGene Bio-Medic… · this assignee
29 score
- China Wafer Level CSP · near 29
China Wafer Level CSP · near
29 score
- SciPharm S à r l · near 29
SciPharm S à r l · near
29 score
- Tervis Tumbler · near 29
Tervis Tumbler · near
29 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Brightgene's Innovation Score is 29.4/100 (30th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Brightgene?
Each dot is one of Brightgene’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Brightgene’s own 12.8 claims/patent is ABOVE the 12.1 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.
Where Brightgene's grants concentrate
BrightGene Bio-Medical Technology Co., Ltd. is a focused PatentsView assignee: 12 CPC subclasses with 72.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2020 (4 grants) versus a trough of 1 in 2017. By volume, Brightgene sits between Brain Games, L.C. and Brownmed, Inc..
Brightgene's three-year grant acceleration
BrightGene Bio-Medical Technology Co., Ltd. shows 1 grants in 2022–2024 against only 8 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at BrightGene's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Brain Games L C
Brain Games, L.C.
11 patents
- Brain
Brain Technologies, Inc.
11 patents
- Bravilor Holding…
Bravilor Holding B.V.
11 patents
- Bridgewest Finance
Bridgewest Finance LLC
11 patents
- Brightsource Indu…
BrightSource Industries (Israel), Ltd.
11 patents
- Brilliant Labs Pr…
Brilliant Labs Private Limited
11 patents
- Broder Bros
Broder Bros., Co.
11 patents
- Brownmed
Brownmed, Inc.
11 patents
- Brightgene Bio-me… ◀
BrightGene Bio-Medical Technology Co., Ltd.
11 patents
What this shows BrightGene holds 11 patents at rank #24,032, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near BrightGene
By rank, the assignees closest to #24,032 in granted patent volume.
- Brain Games, L.C. #24,028 · 11 patents
- Brain Technologies, Inc. #24,029 · 11 patents
- Bravilor Holding B.V. #24,030 · 11 patents
- Bridgewest Finance LLC #24,031 · 11 patents
- BrightSource Industries (Israel), Ltd. #24,033 · 11 patents
- Brilliant Labs Private Limited #24,034 · 11 patents
- Broder Bros., Co. #24,035 · 11 patents
- Brownmed, Inc. #24,036 · 11 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in BrightGene's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for BrightGene, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), BrightGene ranks #2,696 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (29 here).
Brightgene's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
29 30th percentile higher than 30% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2017–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2017 | 1 | 9.1% |
| 2019 | 1 | 9.1% |
| 2020 | 4 | 36.4% |
| 2021 | 3 | 27.3% |
| 2024 | 1 | 9.1% |
| 2025partial year | 1 | 9.1% |
Which technologies does BrightGene Bio-Medical Technology Co., Ltd. patent most?
Top 12 of 12 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
BrightGene Bio-Medical Technology Co., Ltd.'s patent record in context - here's where to go next.
- BrightGene Bio-Medical Technology Co., Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 72.7% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #24,027 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare BrightGene Bio-Medical Technology Co., Ltd. against Brain Games, L.C., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 29.4/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.